Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions.

@article{Pamer2010ChangesIU,
  title={Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions.},
  author={Carol A. Pamer and Tarek A. Hammad and Yu-te Wu and Sigal Kaplan and George Rochester and Laura Governale and Andrew D Mosholder},
  journal={Pharmacoepidemiology and drug safety},
  year={2010},
  volume={19 2},
  pages={158-74}
}
PURPOSE To determine if paroxetine versus non-paroxetine selective serotonin reuptake inhibitors (SSRIs) prescribing changed after the June 2003 FDA Paroxetine Public Health Advisory (PPHA) and if antidepressant and antipsychotic prescribing changed after the February 2004 FDA Advisory Committee Meeting (FDACM). METHODS Ecologic analysis using estimates of patients dispensed antidepressants and antipsychotics, census data, and promotional spending data. Data sources were SDI: Vector One(R… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Outside the Black Box: Re-assessing Pediatric Antidepressant Prescription.

Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent • 2013
View 2 Excerpts

Similar Papers

Loading similar papers…